Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 16 de 16
Filter
Add more filters










Publication year range
1.
Aliment Pharmacol Ther ; 21 Suppl 2: 42-6, 2005 Jun.
Article in English | MEDLINE | ID: mdl-15943846

ABSTRACT

BACKGROUND: In functional gastrointestinal (GI) disorders including functional dyspepsia (FD) and irritable bowel syndrome (IBS), there might be no small extent of contributions of psychosomatic factors. As a therapy for IBS patients, the effectiveness of antidepressants has been reported. AIM: In this study, we evaluated the efficacy of H2-receptor antagonist (famotidine) and 5-HT4 receptor agonist (mosapride citrate). In addition, the effect of antidepressants was assessed as the second-step therapy. METHODS: Patients complaining upper GI symptoms were diagnosed as FD excluding organic diseases. Randomized patients received 20 mg/day of famotidine or 15 mg/day of mosapride citrate for 4 weeks and the efficacy was compared between the two groups based on a 10-point visual analogue scale. When symptoms were not relieved (score improvement 0-2 points), patients received amitriptyline (30 mg/day) or no medication for 4 weeks randomly. Patients who had depression in psychological test (SDS) were omitted. RESULTS: As the first-step therapy, both famotidine and mosapride showed beneficial effects regardless of FD subtypes, age and gender. The efficacy of these two drugs in relieving FD symptoms was not significantly different. In patients who failed in the first-step therapy, amitriptyline showed beneficial effects. CONCLUSIONS: These findings might be clinically important in view of the efficient relief of symptoms in FD patients.


Subject(s)
Amitriptyline/therapeutic use , Benzamides/therapeutic use , Dyspepsia/drug therapy , Famotidine/therapeutic use , Gastrointestinal Agents/therapeutic use , Morpholines/therapeutic use , Aged , Antidepressive Agents, Tricyclic/therapeutic use , Drug Therapy, Combination , Female , Humans , Male , Serotonin Receptor Agonists/therapeutic use
2.
Aliment Pharmacol Ther ; 16 Suppl 2: 20-8, 2002 Apr.
Article in English | MEDLINE | ID: mdl-11966520

ABSTRACT

BACKGROUND AND AIM: It has been suggested that CN (calcineurin, protein phosphatase-2B) regulates signal transduction, particularly in various secretory cells. In this study, we examined whether CN plays a role in stimulus-secretion coupling of gastric parietal cells. MATERIALS AND METHODS: Localization of CN in gastric epithelial cells was examined immunohistochemically. The role of CN in the acid secretion pathway of gastric parietal cells was assessed by evaluating the effect of FK506, a specific inhibitor of CN, on gastric acid secretion in pylorus-ligated rats. In addition, the effect of FK506 on secretagogue (carbachol, tetragastrin and histamine)-stimulated acid secretion was investigated in lumen-perfused rats. RESULTS: CN was specifically expressed in gastric parietal cells and chief cells of the gastric mucosal epithelium immunohistochemically. FK506 dose-dependently inhibited gastric acid secretion in pylorus-ligated rats. In lumen-perfused rats, FK506 completely inhibited acid secretion prestimulated by carbachol and tetragastrin, agonists known to increase cytosolic Ca2+, but did not affect acid secretion prestimulated by histamine. CONCLUSIONS: Our findings demonstrate that FK506 has a potent antisecretory effect in parietal cells through inhibition of only Ca2+-mediated acid secretion pathways. As FK506 is known to specifically inhibit CN, which plays an important role in signal transduction in various secretory cells, protein dephosphorylation signalling might also be crucial for gastrin and M3 muscarine receptor-mediated stimulation of proton pump.


Subject(s)
Calcineurin Inhibitors , Calcium/metabolism , Gastric Acid/metabolism , Gastric Mucosa/metabolism , Animals , Calcineurin/physiology , Depression, Chemical , Gastric Acidity Determination , Gastric Mucosa/drug effects , Immunohistochemistry , Male , Rats , Rats, Sprague-Dawley , Signal Transduction , Tacrolimus/pharmacology
3.
J Gastroenterol Hepatol ; 16(10): 1105-11, 2001 Oct.
Article in English | MEDLINE | ID: mdl-11686836

ABSTRACT

BACKGROUND: Interleukin-1 (IL-1) and tumor necrosis factor-alpha (TNF-alpha) are believed to play a significant role in the pathogenesis of inflammatory bowel disease (IBD). Interleukin-1 and TNF-alpha possess overlapping and synergetic activities inducing the production in cascade of other cytokines, adhesion molecules, arachidonic acid metabolites, as well as activating immune and non-immune cells. FR167653 (C24H18FN5O2-H2SO4-H2O) is a newly synthesized organic compound with a potent inhibitory effect on IL-1beta and TNF-alpha production. We hypothesized that the suppression of IL-1 and TNF-alpha induced by FR167653 could effectively attenuate experimentally induced colonic damage. METHODS: Colonic lesions were induced in male Sprague-Dawley rats (250-300 g) by intrarectal instillation of 4% acetic acid. The effect of FR167653 administration at 1.0, 1.5, 2.5 mg/kg per 6 h subcutaneously on acetic acid-induced colonic damage was assessed. The lesion area, microscopic findings, colonic and serum levels of TNF-alpha and IL-1beta were also evaluated. RESULTS: Treatment with FR167653 at 1.5 and 2.5 mg/kg per 6 h was able to ameliorate the gross macroscopic appearance of colonic lesions significantly, as well as ameliorate the lesion area induced by acetic acid. Colonic mucosal TNF-alpha and IL-1beta levels of rats treated with FR167653 showed significant decrease in a dose-dependent fashion compared with the control group. In the same manner, serum TNF-alpha of rats treated with FR167653 was significantly lower than that of respective controls. CONCLUSIONS: Subcutaneous administration of FR167653 was able to ameliorate the acute changes induced by acetic acid instillation in a dose-dependent manner. This is the first report to evaluate the dual inhibition of the production of IL-1 and TNF-alpha, offered by FR167653, in acute experimental colitis. Further studies are necessary to evaluate FR167653's efficacy and safety on long-term conditions.


Subject(s)
Anti-Inflammatory Agents, Non-Steroidal/pharmacology , Colitis/prevention & control , Interleukin-1/antagonists & inhibitors , Pyrazoles/pharmacology , Pyridines/pharmacology , Tumor Necrosis Factor-alpha/antagonists & inhibitors , Acetic Acid , Acute Disease , Analysis of Variance , Animals , Disease Models, Animal , Interleukin-1/biosynthesis , Interleukin-1/blood , Male , Molecular Structure , Pyrazoles/chemistry , Pyridines/chemistry , Rats , Rats, Sprague-Dawley , Tumor Necrosis Factor-alpha/biosynthesis
4.
Dig Dis Sci ; 45(7): 1480-9, 2000 Jul.
Article in English | MEDLINE | ID: mdl-10961734

ABSTRACT

In order to study the cytoprotective function of colonic heat shock proteins (HSPs) in vivo, the effect of specific preinduction of HSP60 by thyrotropin-releasing hormone (TRH) administration on the development of acetic acid-induced colonic mucosal lesion was investigated. Expression of 60-kDa, 72-kDa, and 90-kDa heat shock proteins (HSP60, HSP72, and HSP90, respectively) in rat colonic mucosa was investigated by western blot and immunohistochemical analyses before and after TRH administration. Following pretreatment with or without TRH administration, the rats received intrarectal infusion of 5% acetic acid. The colonic mucosal damage was macroscopically evaluated 24 hr after the intrarectal infusion of acetic acid. Expression of HSP60 was significantly increased by TRH administration in the colonic mucosa, whereas HSP72 and HSP90 did not increase. Immunohistochemical study also showed a significant increase in HSP60 in colonic mucosal cells, especially at the surface of the colonic mucosa after TRH administration. No histopathologic alteration was observed in the colonic mucosa after TRH administration. The colonic mucosal damage caused by intrarectal infusion of 5% acetic acid was not prevented by preinduction of HSP60. We demonstrated that specific preinduction of HSP60 by TRH administration did not show cytoprotective function in the colonic mucosa, although this protein plays a crucial role for cytoprotection in the pancreatic acinar cells. Our results indicate that the role of HSP60 may be different in each organ with respect to cytoprotection.


Subject(s)
Acetic Acid/pharmacology , Chaperonin 60/metabolism , Colon/drug effects , Colonic Diseases/chemically induced , Colonic Diseases/prevention & control , Intestinal Mucosa/drug effects , Thyrotropin-Releasing Hormone/pharmacology , Animals , Colon/pathology , Colonic Diseases/pathology , Dose-Response Relationship, Drug , Immunohistochemistry , Intestinal Mucosa/pathology , Male , Rats , Rats, Sprague-Dawley
5.
J Gastroenterol ; 35(5): 369-71, 2000.
Article in English | MEDLINE | ID: mdl-10832672

ABSTRACT

Cyclosporin A is an immunosuppressive agent which is well known as a specific inhibitor of calcineurin (protein phosphatase 2B). In this study, we investigated the effects of cyclosporin A on water-immersion stress-induced gastric ulcer formation and gastric acid secretion in rats. We also examined the localization of calcineurin immunohistochemically. Calcineurin was specifically expressed in gastric parietal cells and chief cells of the gastric mucosa. The intraperitoneal administration of cyclosporin A dose-dependently suppressed the development of gastric mucosal lesions induced by water-immersion stress and inhibited gastric acid secretion, as assessed by pylorus ligation. These results indicated that calcineurin may play an important role in gastric acid secretion.


Subject(s)
Cyclosporine/pharmacology , Gastric Acid/metabolism , Gastric Mucosa/drug effects , Immunosuppressive Agents/pharmacology , Stomach Ulcer/prevention & control , Stress, Physiological/complications , Animals , Calcineurin/metabolism , Calcineurin Inhibitors , Dose-Response Relationship, Drug , Gastric Mucosa/metabolism , Gastric Mucosa/pathology , Immersion/adverse effects , Injections, Intraperitoneal , Male , Rats , Rats, Sprague-Dawley , Stomach Ulcer/etiology , Stomach Ulcer/metabolism , Stomach Ulcer/pathology
6.
Dig Dis Sci ; 45(12): 2337-46, 2000 Dec.
Article in English | MEDLINE | ID: mdl-11258553

ABSTRACT

One of the important problems in experimentally induced small intestinal lesions is that there is no reproducible model of diffuse and stable mucosal lesion. In this paper, we studied in detail the effects of continuous perfusion of various concentrations of acetic acid on the rat small intestinal mucosa. In order to evaluate its applicability for screening of the preventive effect of drugs on gut damage, we also evaluated the efficacy of corticosteroid pretreatment in preventing acetic acid-induced mucosal lesion. Male Sprague-Dawley rats were fasted for 12 hr, and the small intestinal lumen was perfused with 1%, 1.5%, 2.5%, 3%, 3.75% (pH 2.4-2.6) acetic acid or saline (control) at 1 ml/min for 15 min. In separate experiments, the effect of preadministration of budesonide (0.5 or 0.75 mg/kg/day) and prednisone (0.75 mg/kg/day) on 1.5% acetic acid-induced mucosal damage was investigated. Macroscopic and microscopic lesions occurred diffusely in a concentration-dependent fashion. Histological findings revealed signs of transmural inflammation characterized by mucosal-submucosal edema, ulceration, and neutrophil infiltration. Mucosal-submucosal height had an inverse relation with the acetic acid concentrations perfused. Myeloperoxidase activity levels increased several-fold in the acetic acid-perfused groups. Corticosteroid pretreatment prevented microscopic damage and was associated with reduction of MPO activity levels in 1.5% acetic acid-perfused rats. We conclude that this simple and reproducible model could be applied for the screening of new drugs in the gastrointestinal tract in which large numbers of animals are taken into account.


Subject(s)
Acetic Acid/pharmacology , Anti-Inflammatory Agents/pharmacology , Budesonide/pharmacology , Intestinal Mucosa/drug effects , Intestine, Small/drug effects , Prednisone/pharmacology , Animals , Drug Evaluation, Preclinical/methods , Intestinal Mucosa/enzymology , Intestinal Mucosa/pathology , Intestine, Small/enzymology , Intestine, Small/pathology , Male , Models, Animal , Perfusion , Peroxidase/metabolism , Rats , Rats, Sprague-Dawley
7.
Dig Dis Sci ; 44(7): 1401-7, 1999 Jul.
Article in English | MEDLINE | ID: mdl-10489926

ABSTRACT

It is well documented that gastric mucosa can increase its resistance to mucosal damage caused by aspirin during repeated long-term administration of aspirin. However, the underlying mechanism of this adaptation is not well established. In the present study, we investigated the effect of long-term (chronic) administration of aspirin on expression of heat shock proteins (HSPs), which are known as endogenous cytoprotectants, in rat gastric mucosa. Rats were administered aspirin (100 mg/kg) daily for up to 20 days. After various periods of aspirin administration, a high dose of aspirin (250 mg/kg) was administered, and the mucosal damage was assessed. Expression of heat shock proteins (HSPs) in gastric mucosa was evaluated by Western blot. Intracellular localization of each HSP was studied immunohistochemically. Prostaglandin E2 (PGE2) and leukotriene B4 (LTB4) levels were also investigated. Long-term aspirin administration resulted in development of resistance to aspirin-induced mucosal damage, and the increase of HSP72 expression correlated with mucosal resistance to aspirin. No significant increase was observed in HSP60 and HSP90 levels. Immunohistochemical study showed an increase of HSP72 in the cytoplasm of mucosal surface cells. The PGE2 level was suppressed and no change in the level of LTB4 was observed. It is possible that HSP72 could play important roles in gastric mucosal adaptation when the PGE2 level is suppressed by NSAIDs.


Subject(s)
Anti-Inflammatory Agents, Non-Steroidal/toxicity , Aspirin/toxicity , Gastric Mucosa/drug effects , Heat-Shock Proteins/genetics , Adaptation, Physiological/genetics , Animals , Dinoprostone/metabolism , Gastric Mucosa/pathology , Gene Expression/drug effects , HSP72 Heat-Shock Proteins , Immunoenzyme Techniques , Leukotriene B4/metabolism , Long-Term Care , Male , Rats , Rats, Sprague-Dawley
9.
Dig Dis Sci ; 43(9): 2117-30, 1998 Sep.
Article in English | MEDLINE | ID: mdl-9753281

ABSTRACT

Bowel dysfunction such as irritable bowel syndrome caused by stress is well described. Previous reports suggest that stress is known to cause the release of endogenous substances such as catecholamine, beta-endorphine, 5-hydroxytryptamine, corticotropin-releasing factor, and thyrotropin-releasing hormone (TRH). However, the role played by these neurohormonal mediators in bowel dysfunction under stress conditions is not well known. We investigated the influence of water-immersion stress or TRH administration on the expression of 60-kDa, 72-kDa, and 90-kDa heat-shock proteins (HSP60, HSP72, and HSP90, respectively) in rat small intestinal mucosa by Western blot and immunohistochemical analyses. The cytoprotective function of preinduced HSPs on experimentally induced mucosal damage also was studied. In order to investigate the influence of preinduction of HSP60 on small intestinal damage, the small intestinal lumen was perfused with 1.5% acetic acid 1 ml/min for 15 min with or without pretreatment with water-immersion stress or TRH administration. Expression of HSP60 was significantly increased by water-immersion stress or TRH administration in the small intestinal mucosa, whereas HSP72 and HSP90 did not increase. Interestingly, expression of this protein showed the biphasic peak pattern after water-immersion stress or TRH administration. Each peak was observed 3-6 hr and 21-24 hr after the initiation of water-immersion stress or TRH administration. Immunohistochemical study also showed a significant increment of HSP60 in both the cytoplasm and nuclei of the small intestinal mucosal cells. No histopathologic alteration was observed in rat small intestinal mucosa after each treatment. Small intestinal damage caused by 1.5% acetic acid perfusion was not influenced by preinduction of HSP60. We demonstrated that water-immersion stress or TRH administration specifically induced HSP60, although preinduction of this protein did not show a cytoprotective function in the small intestinal mucosa.


Subject(s)
Heat-Shock Proteins/metabolism , Intestinal Mucosa/metabolism , Intestine, Small/metabolism , Acetic Acid , Animals , Chaperonin 60/metabolism , HSP72 Heat-Shock Proteins , Immersion/adverse effects , Intestinal Mucosa/drug effects , Intestinal Mucosa/pathology , Intestine, Small/drug effects , Intestine, Small/pathology , Male , Rats , Rats, Sprague-Dawley , Stress, Physiological/metabolism , Thyrotropin-Releasing Hormone/metabolism , Time Factors , Up-Regulation , Water
10.
Dig Dis Sci ; 42(7): 1473-9, 1997 Jul.
Article in English | MEDLINE | ID: mdl-9246049

ABSTRACT

We previously reported that water-immersion stress specifically induced the synthesis of a 60-kDa heat-shock protein (HSP60, chaperonin homolog) in pancreatic cells and preinduction of HSP60 completely prevented development of cerulein-induced pancreatitis in the rat in an HSP60 quantitatively dependent manner. In order to study the cytoprotective function of a 72-kDa heat-shock protein (HSP72, stress-inducible hsp70), the effect of specific preinduction of HSP72 by hyperthermia on cerulein-induced pancreatitis was investigated and compared with the effect of preinduction of HSP60 in this study. Expression of HSP60 and HSP72 in the pancreas was investigated by immunoblot before and after water immersion or hyperthermia. Following pretreatment with water-immersion stress or hyperthermia, the rats were injected with cerulein (40 micrograms/kg, intraperitoneally). The pancreas wet weight and serum amylase concentration were measured before and after cerulein injection. Hyperthermia (42.5 degrees C, 20 min) specifically induced HSP72 in the pancreas. The synthesis of HSP60 was specifically induced by water-immersion stress in the pancreas. Cerulein-induced pancreatitis was clearly prevented by specific preinduction of HSP60 by water-immersion stress. However, preinduction of HSP72 by hyperthermia had no preventive effect on cerulein-induced pancreatitis. Our findings suggest that HSP60 and HSP72 have distinct functions in the pancreas, and their induction mechanisms are also different in vivo. These results could be important for understanding the mechanism of "adaptive cytoprotection" in the pancreas mediated by heat-shock proteins.


Subject(s)
Chaperonin 60/biosynthesis , Heat-Shock Proteins/biosynthesis , Pancreatitis/prevention & control , Stress, Physiological/metabolism , Amylases/blood , Animals , Ceruletide , Chaperonin 60/physiology , HSP72 Heat-Shock Proteins , Heat-Shock Proteins/physiology , Hyperthermia, Induced , Immersion , Male , Pancreas/pathology , Pancreatitis/chemically induced , Pancreatitis/metabolism , Rats , Rats, Sprague-Dawley
11.
J Clin Gastroenterol ; 25(1): 383-6, 1997 Jul.
Article in English | MEDLINE | ID: mdl-9412929

ABSTRACT

We describe cystic lymphangiomatosis with intestinal bleeding developing multiple lymphangiomas in the small intestine, mesentery, mesocolon, omentum, retroperitoneum, and spleen. Small intestinal fluorography showed multiple polypoid lesions, mainly in the jejunum. Ultrasonography, computed tomography, and magnetic resonance imaging showed diffuse cystic tumors in the mesentery and spleen. Cystic lymphangiomatosis was proved by histologic findings of the biopsied specimen at laparotomy.


Subject(s)
Abdominal Neoplasms/pathology , Gastrointestinal Hemorrhage/complications , Lymphangioma, Cystic/pathology , Abdominal Neoplasms/complications , Abdominal Neoplasms/diagnostic imaging , Adult , Humans , Lymphangioma, Cystic/complications , Lymphangioma, Cystic/diagnostic imaging , Magnetic Resonance Imaging , Male , Tomography, X-Ray Computed
14.
Br J Nutr ; 66(3): 399-405, 1991 Nov.
Article in English | MEDLINE | ID: mdl-1772867

ABSTRACT

The mean retention time (MRT) of stained hay through the whole digestive tract and its digestibility were measured in Japanese sika deer (Cervus nippon) and were compared with those in sheep when lucerne (Medicago sativa) hay was fed at 10, 20 and 30 g/kg body-weight. The recoveries in faeces of plastic particles with five specific gravities were also measured in deer. MRT for deer was significantly shorter than that for sheep at 10 and 20 g/kg feeding levels. The digestibilities of dry matter, organic matter, and neutral-detergent fibre were significantly lower for deer than for sheep at 30, 30 and 10 g/kg feeding levels respectively. The recovery rates of plastic particles were increased, but the ruminated rates were decreased, with increasing specific gravity in deer. These results suggest that the lower digestibility of lucerne hay in Japanese deer may be due to a shorter MRT compared with sheep.


Subject(s)
Deer/physiology , Digestion/physiology , Gastrointestinal Transit/physiology , Medicago sativa , Sheep/physiology , Animals , Eating/physiology , Feces/chemistry , Male
SELECTION OF CITATIONS
SEARCH DETAIL
...